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Background: Chronic obstructive pulmonary disease (COPD) is an epidemic and progressive health problem which
is mainly a consequence of cigarette smoking, and associated with lung inflammation. Anti-inflammatory property
of Zataria multiflora (Z. multiflora) and its constituent, carvacrol was shown in various inflammatory disorders previously.
Therefore, in the present study, the effects of the plant and its constituent, carvacrol, on lung inflammation changes
and oxidative stress, in guinea pigs model of COPD were evaluated.
Methods: Nine groups of animals including control, COPD, COPD + drinking water containing three concentrations of
extract of Z. multiflora (0.4, 0.8, and 1.6 mg/mL), COPD + drinking water containing three concentrations of carvacrol
(60, 120, and 240 μg/mL), and COPD + dexamethasone (50 μg/mL) were studied. For inducing COPD, animals
were exposed to cigarette smoke for 3 months. Thiol groups, IL-8, total and differential WBC were measured in
broncho-alveolar lavage fluid (BALF) (n = 6 for each group).
Results: Total WBC, eosinophils, and neutrophils counts as well as the levels of IL-8 in BALF were significantly
increased but thiol group was decreased in COPD compared to the control group (p < 0.05 to p < 0.001). Total
WBC and IL-8 in all treated COPD groups, thiol group, eosinophils and neutrophils counts in treated groups with
dexamethasone and two higher concentrations of the Z. multiflora and carvacrol were significantly improved compared
to non-treated COPD group (p < 0.05 to p < 0.001). Lymphocyte count in treated groups with dexamethasone, highest
concentration of Z. multiflora, and two higher concentration of carvacrol was also significantly higher than non-treated
group (p < 0.05 to p < 0.001).
Conclusions: A preventive effect of Z. multiflora extract and its constituent carvacrol on lung inflammation changes
and oxidative stress in animal model of COPD was suggested.
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Chronic obstructive pulmonary disease (COPD), with
smoking as an important risk factor for its development [1]
is an epidemic and progressive world health problem [2].
Inflammatory processes, oxidative damage, proteolysis,
vascular remodeling, and lung tissue changes of COPD
are well-documented changes in this disease [3]. CD68+* Correspondence: boskabadymh@mums.ac.ir
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article, unless otherwise stated.monocytes or macrophages in the bronchial mucosa [4],
TNFα, interleukin-8, and macrophage inflammatory
protein-1α (MIP-1α) which produce a positive inflam-
matory chain are increased in COPD [5]. An increase
in the number of neutrophils is also observed in severe
COPD patients [6]. It was shown that antioxidants
may have a role in the treatment of COPD patients [7].
Animal model of COPD using cigarette smoke exposure
has been induced in guinea pigs which leads to emphyse-
matous lung destruction and lung inflammation [8-10].ee BioMed Central. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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grows in Iran, Pakistan, and Afghanistan [12]. Z. multi-
flora is used in Iranian traditional medicine for antisep-
tic, analgesic, and carminative properties [13]. Different
pharmacological effects including analgesic [14,15], anti-
oxidant [16], antitussive [17], and anti-inflammatory
effects [15] were shown for this plant. In our previous
studies, the inhibitory effect of the extracts from Z.
Multiflora and carvacrol on histaminergic (H1) [18] and
muscarinic receptors [19-21] and its stimulatory effect
on β-adrenoceptors [22] as well as the effect of the plant
on systemic inflammation of cigarette smoke exposed
animals [23] were demonstrated. The medicinal use of all
plants containing carvacrol including Z. multiflora on
respiratory diseases were also described [24,25]. In
addition, various pharmacological effects including anti-
inflammatory [26,27] and relaxant properties [28,29]
were shown for carvacrol.
Therefore, in the present study, the effects of Z. multiflora
and carvacrol on lung inflammatory changes and oxidative
stress on guinea pig model of COPD have been examined.
Methods
Plant and extract
Z. multiflora was collected from mountains in the mine
fluorine area, in the region between Tabas and Yazd,
centre of Iran, and identified by Mr. Joharchi and a con-
trol sample was kept in the Herbarium of the Faculty of
Sciences, Ferdowsi University of Mashhad (herbarium
number: 35314). Hydro-ethanolic extract of 125 g dried
shoots and powdered Z. multiflora was prepared by
mixing it with 875 mL of 50% ethanol and shaking for
72 hours at room temperature. The extract was then
passed through the filter paper and the solvent was re-
moved under reduced pressure. The yield extract from the
plant was 18.7 g. The dried extract was collected and kept
at refrigerator temperature for experimental purpose.
Characterization of the extract of Zataria multiflora
The characteristic of the extract of this plant was identi-
fied using HPLC (Waters 474, Waters Corporation, MA,
USA) fingerprint as described in our previous study [22],
(Figure 1).
Animals and groups
Fifty four guinea pigs of both sexes (600–800 g) were
purchased from Razi Institute, Mashhad, Iran and were
kept at 22 ± 2°C on a 12 h light/dark cycle during the
study period. Experiments were performed in compli-
ance with the regulations of the Institute of Laboratory
Animals Resources, Commission on Life Sciences [30].
Animals were divided into nine groups in a random
order which received drinking water as follow (for each
group, n = 6):1) Control group: the animals were exposed to ambient
air and received drinking water alone.
2) COPD group: the animals were exposed to cigarette
smoke and received drinking water alone.
3) COPD + dexamethasone (Sigma Chemical Company,
Ltd, Poole, Dorset BH12 4QH, UK, purities ≥97%):
the animals were exposed to cigarette smoke and
received drinking water containing 50 μg/mL
dexamethasone.
4) COPD + Z. multiflora dose 1: the animals were
exposed to cigarette smoke and received drinking
water containing 0.4 mg/mL of the extract.
5) COPD + Z. multiflora dose 2: the animals were
exposed to cigarette smoke and received drinking
water containing 0.8 mg/mL of the extract.
6) COPD + Z. multiflora dose 3: the animals were
exposed to cigarette smoke and received drinking
water containing 1.6 mg/mL of the extract.
7) COPD + carvacrol (Sigma Chemical Company, Ltd,
Poole, Dorset BH12 4QH, UK, purities ≥98%) dose 1:
the animals were exposed to cigarette smoke and
received drinking water containing 60 μg/mL carvacrol.
8) COPD + carvacrol dose 2: the animals were exposed
to cigarette smoke and received drinking water
containing 120 μg/mL carvacrol.
9) COPD + carvacrol dose 3: the animals were exposed
to cigarette smoke and received drinking water
containing 240 μg/mL carvacrol.
The extract, carvacrol, or dexamethasone, were added
to the drinking water daily which was freely available to
animals during the period of cigarette smoke exposure
(3 months). The volume of uptake of drinking water was
checked regularly which was about 100 mL/day for each
guinea pig in all of the groups. Although carvacrol and
ethanolic extract are lipophilic compounds but due to
their low concentration used in the present study, they
were well emulsified in drinking water.
Exposure of animals to cigarette smoke
Guinea pigs were exposed to cigarette smoke in order to
induce animal model COPD, as previously described
[31,32]. Briefly, animals were placed in two chamber
box; a smaller closed chamber for the head with a hole
at its top for delivering of cigarette smoke to the animal’s
head and a larger opened part for the body of guinea
pigs. The animal’s neck was fixed between the two
chambers by a sliding pyrepex sheet. Each animal was
initially exposed to one cigarette per day which was
gradually increased to a maximum of 5 cigarettes per
day over a period of 20 days. The animals were exposed
to smoke of 5 cigarette/day, 5 days per week (Magna:
Nicotine = 5, tar = 6, the cigarettes’ filters weren’t removed)
for 70 days. Therefore, each animal was exposed to
Figure 1 Fingerprint of (a) the extract of Z. multiflora (50 μg/mL) and (b) chromatographic profile of pure carvacrol (C10H14O, 5/1000)
with retention time of about 9 min. MW= 150.217 (Ref [22]).
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Cigarette smoke was drawn into a 20 mL syringe and
exhausted at a rate of two puffs per minute into the ani-
mals’ head chamber. The exposure of animals to the smokeof each cigarette was taken 8–9 minutes and there was a
10-minute break between the two cigarettes. The study was
approved by the Ethical Committee of Mashhad University






























































Figure 2 Total WBC count (in 1 mL) in BALF of control, COPD,
and COPD treated with dexamethasone, three concentrations
of Z. multiflora (a), and carvacrol (b). ###; p < 0.001 compared to
control group. **; p < 0.01, ***; p < 0.001 compared to non-treated
COPD group.
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Broncho-alveolar lavage fluid (BALF) was prepared from
the lung following animal sacrificing and opening of
their chest. A cannula was placed into the trachea and
lungs were lavaged with 2 mL of saline for 5 times (total
10 mL). BALF was then centrifuged at 2500 × g for
10 min and the supernatant was collected for measure-
ment of thiol group and IL-8 concentration.
Total thiol group was measured as previously described
[33]. In summary, 1 mL Tris-EDTA buffer was added to
50 μL of BALF and sample absorbance was read at 412 nm
against Tris-EDTA buffer alone (A1). Then, 20 μL 2,2-dini-
tro-5,5′-dithiodibenzoic acid (10 mM in methanol) reagent
(DTNB) was added to the mixture. DTNB reacts with the
SH groups to produce a yellow colored complex with
peak absorbance at 412 nm. The sample absorbance
was read again after 15 min (A2). Total thiol concentra-
tion was calculated according to the following formula:
Total thiol mMð Þ ¼ A2‐A1‐blankð Þ  1:07=0:05
 13:6:
The level of IL-8 was measured using a double antibody
sandwich enzyme-linked immunosorbent assay (ELISA)
kit (Hangzhou Eastbiopharm Co., Ltd., Hangzhou, China)
according to the manufacturer’s protocol.
Total and differential WBC measurement
BALF sample was taken from the lung and then trans-
ferred into the test tube containing anticoagulant EDTA.
Total WBC was counted in duplicate in a hemocytometer
(in a Burker chamber) in blood stained with Turk solution.
Differential cell counts were performed on thin slide, pre-
pared with smearing BALF sample using Wright-Giemsa’s
stain. According to staining and morphological criteria,
differential cell analysis was carried out under a light
microscope by counting 100 cells and calculating the per-
centage of each cell type.
Statistical analysis
Data were expressed as mean ± SEM. Comparisons be-
tween the results of COPD and control groups were per-
formed using unpaired t-test. The data of treated groups
were also compared with non-treated COPD group using
unpaired t-test. The comparisons between the data of ani-
mals treated with three concentrations of Z. multiflora and
carvacrol were performed using ANOVA with Tukey-
Kramer post test. Significance was accepted at p < 0.05.
Statistical analyses were made using GraphPad Instat ver-
sion 3.00 (GraphPad Software, San Diego, California, USA).
Results
Total WBC (p < 0.001), neutrophils and eosinophils
counts (p < 0.05 for both cases) in BALF of COPD weresignificantly higher compared to control group (Figures 2
and 3). Total WBC number in all treated groups and
eosinophil and neutrophil percentage in the treated
groups with dexamethasone and highest concentration
of the extract and two higher concentrations of carva-
crol were significantly improved compared to COPD
group (p < 0.05 to p < 0.001). In addition, lymphocyte
percentage in treated groups with dexamethasone,
highest concentration of Z. multiflora and two higher
concentrations of carvacrol were significantly in-
creased compared to COPD group (p < 0.05 to p < 0.01,
Figures 2 and 3).
Figure 3 Differential WBC counts as the percentage of total WBC in BALF of control, COPD, and COPD treated with dexamethasone, three
concentrations of Z. multiflora (a), and carvacrol (b). #; p < 0.05 compared to control group. *; p < 0.05, **; p < 0.01 compared to non-treated
COPD group.
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was significantly decreased compared to control group
(p < 0.001). In COPD groups treated with dexame-
thasone, two higher concentrations of Z. multiflora and
carvacrol, the value of thiol group was significantly
increased compared to the COPD animals (p < 0.01 to
p < 0.001, Figure 4).
The level of IL-8 in BALF of COPD group was signifi-
cantly increased compared to control group (p < 0.05).
In treated groups with dexamethasone, three concentra-
tions of Z. multiflora and carvacrol, the level of IL-8 wassignificantly lower than COPD group (p < 0.001, for all
cases, Figure 5).
Although the effects of treatment with low concentra-
tion of the extract and carvacrol on total WBC, eosino-
phil, neutrophil, and thiol group were significantly lower
than the effect of their highest concentration, on thiol
group, it was higher compared to the effect of dexa-
methasone (p < 0.05 to p < 0.001, Tables 1 and 2). How-
ever, there was no significant difference in the level of
IL-8 in BALF between treated groups with different
concentrations of the extract and carvacrol compared to
Figure 4 The level of thiol group in BALF of control, COPD, and COPD treated with dexamethasone, three concentrations of Z.
multiflora (a), and three concentrations of carvacrol (b). ###; p < 0.001 compared to control and **; p < 0.01, ***; p < 0.001 compared to
non-treated COPD group.
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medium and high concentrations of the extract on total
and differential WBC counts were not significantly dif-
ferent than the effect of dexamethasone (Table 1).
There was no significant difference between the effect of
treatment using different concentrations of carvacrol with
their corresponding extract concentration (Tables 1 and 2).
The effects of treated COPD groups with highest con-
centration of the extract and carvacrol on all measured
parameter except for IL-8 was significantly higher than
their lowest concentration (p < 0.05 to p < 0.001, Tables 1
and 2). The effects of medium concentration carvacrol on
all parameters except for IL-8 and the effect of medium
extract concentration on total WBC and eosinophil counts
and thiol group was also significantly higher than the
effect of their lowest concentration (p < 0.05 to p < 0.001,
Tables 1 and 2). In addition, the effect of highest extract
concentration on thiol group was also significantly higher
than its medium concentration (p < 0.05, Table 2).
Discussion
The exposure of animals to cigarette smoke resulted in a
significant increase of BALF total WBC, eosinophils andneutrophils counts, and IL-8 but decrease in thiol group
compared to non-exposed control animals. Several pre-
vious studies have shown the induction of animal model
of COPD by cigarette smoke exposure using similar
method used in the present study [10,31,32]. It was also
shown that inflammatory cells play an important role
in COPD including macrophages and neutrophils [34].
Eosinophils are a source of cytokines IL-3, 4, 5, 6, 8,
and eosinophil-derived neurotoxin as well as eosinophil
peroxidase that have a role in the pathogenesis of
COPD. An increase in IL-8 level in smokers with
COPD compared to healthy people was also observed
previously [34].
According to the results of the present study, oxidative
stress was increased in the COPD group in their BALF
measured by a decrease in the thiol groups. Previous
study confirmed the presence of the oxidative stress in
COPD [10]. It was also proven that cigarette smoke con-
tains stable compounds that undergo redox-cycle and
form reactive oxygen species such as superoxide radicals,
hydrogen peroxide, and hydroxyl radicals [35].
With regard to beneficial effect of Z. multiflora on the
bronchial inflammation which was reported in traditional
Figure 5 The level of IL-8 in BALF of control, COPD, and COPD treated with dexamethasone, three concentrations of Z. multiflora (a)
and carvacrol (b). #; p < 0.05 compared to control group. ***; p < 0.001 compared to non-treated COPD group.
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of Z. multiflora and its constituent carvacrol in animals
exposed to cigarette smoke (an animal model of COPD)
were studied. Total WBC, eosinophils and neutrophils
counts as well as IL-8 level in BALF were significantly
decreased and thiol group was significantly increased in
COPD groups treated with at least two higher concentra-
tions of the extract of Z. multiflora and carvacrol. These








Total WBC 2.08 ± 0.11+++ 1.04 ± 0.82### 0.89 ± 0.62###
Eosinophil 3.33 ± 0.33++ 1.83 ± 0.40+,# 1.00 ± 0.25##
Neutrophil 37.16 ± 1.19+ 34.33 ± 1.64 31.50 ± 1.17#
Monocyte 11.66 ± 0.76 130 ± 0.96 14.66 ± 1.40
Lymphocyte 47.83 ± 1.64 50.83 ± 1.16 52.83 ± 1.01#
Data are presented as mean ± SEM. WBC is expressed as its count in 1 mL BALF and
p < 0.01, +++; p < 0.001 compared to the effect of dexamethasone using unpaired t
concentration of Z. multiflora and carvacrol, using (ANOVA) with Tukey–Kramer mulmultiflora and its constituent carvacrol in the deve-
lopment of COPD. Previous studies have also shown
anti-inflammatory effects of Z. multiflora and its con-
stituents, which support the results of the present study
[37,38]. Increased thiol group in BALF of COPD
animals treated with two higher concentrations of Z.
multiflora and carvacrol seen in the present study was
supported by the antioxidant effect of Z. multiflora [16]









2.05 ± 0.15+++ 1.00 ± 0.75### 0.80 ± 0.76### 1.21 ± 0.92
2.83 ± 0.60++ 0.80 ± 0.37# 0.83 ± 0.307### 0.83 ± 0.40
38.16 ± 1.53++ 32.20 ± 1.46# 29.50 ± 1.58## 30.83 ± 1.01
12.66 ± 1.54 13.60 ± 0.51 13.33 ± 0.91 14.50 ± 1.25
46.33 ± 1.85 53.4 ± 0.92# 56.33 ± 1.28### 53.83 ± 1.30
those of each type of WBC is the percentage of total WBC. +; p < 0.05, ++;
-test. #; p < 0.05, ##; p < 0.01. ###; p < 0.001, compared to the effect of low
tiple post test.
















Thiol (mM) 44.33 ± 1.84+++ 55.15 ± 1.27### 68.34 ± 4.06+,###,¶ 46.66 ± 3.52+¶ 64.08 ± 5.81# 76.01 ± 2.32+++,### 58.20 ± 1.82
IL-8 (pg/mL) 409.15 ± 6.84 375.21 ± 15.31 396.74 ± 15.84 412.53 ± 11.16 416.66 ± 16.91 383.46 ± 34.35 375.02 ± 21.15
Data are presented as mean ± SEM. +; p < 0.05, +++; p < 0.001, compared to the effect of dexamethasone using unpaired t-test. #; p < 0.05, ###; p < 0.001, compared to
the effect of low concentration of Z. multiflora and carvacrol, and ¶; p < 0.05, compared to the effect their medium concentration using (ANOVA) with Tukey–Kramer
multiple post test.
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and carvacrol could be another indicator of the prevent-
ive effect of the plant and its constituent, carvacrol on
COPD. However, the effect of the extract and carvacrol
on IL-8 was not fully concentration-dependent and
there was no significant difference between the effects
of three concentrations. The most probable explanation
for these findings is the achievement of maximum
concentration at lower concentration of the extract and
carvacrol. However, the exact explanation for this
observation should be examined in future studies. Car-
vacrol concentrations used in the present study were
about 15% of Z. multiflora concentrations, which are
lower than the actual concentration in the plant [41].
Therefore, the similar effects of carvacrol with Z. multi-
flora on lung inflammatory changes and oxidative stress
suggest that carvacrol is responsible for the observed
results for Z. multiflora.
In the present study, dexamethasone was used as posi-
tive control because it is effective in treatment of COPD
by its anti-inflammatory property [42-44]. Total WBC,
eosinophil and neutrophil counts, as well as IL-8 were
also significantly reduced and thiol group was increased
in COPD animals treated with dexamethasone. Although
the effect of lower concentration of the extract and car-
vacrol was smaller than the dexamethasone, the prevent-
ive effects of their medium and high concentrations
were similar to dexamethasone. Similar effects of dexa-
methasone on measured variables with the effects of Z.
multiflora and its constituent carvacrol also support the
preventive effect of the plant and carvacrol on develop-
ment of COPD with anti-inflammatory mechanism. In
fact, in our previous studies, the anti-inflammatory effect
of Z. multiflora and its constituent carvacrol on sensi-
tized guinea pigs [45,46] and the effects of the plant on
systemic inflammation of cigarette smoke exposed ani-
mals [23] were shown which further support the findings
of the present study.
Various pharmacological effect of Z. multiflora and its
constituent, carvacrol on animal model of asthma, ani-
mal model of COPD, the relaxant effect of the plant and
carvacrol, and its possible mechanisms were examined.
In line with our previous studies, the preventive effect of
Z. multiflora and carvacrol on lung inflammation inanimal model of COPD (exposed guinea pig to cigarette
smoke) was examined in the present study which is
novel and showed promising results.
The results of the present study showed a preventive
effect of Z. multiflora and its constituent carvacrol on
COPD with anti-inflammatory and antioxidant mecha-
nisms. In fact, anti-inflammatory effect of this plant was
also addressed in a recent review [47]. Therefore, these
results suggested an anti-inflammatory and antioxidant
or preventive effect for Z. multiflora on animal model of
COPD (exposed animals to cigarette smoke). The relaxant
effect of carvacrol showed in previous studies [28,29] and
the results of the present study may suggest the thera-
peutic potentials of the plant on COPD by both bronch-
dilatory and anti-inflammatory mechanisms. However,
the effect of different constituents of the plant on ani-
mal model of COPD as well as the effect of the extract
and its constituents on COPD patients should be examined
in further studies.Conclusions
In conclusion, the results of the present study indicated
a preventive effect of Z. multiflora and carvacrol on
BALF total and differential WBC, BALF levels of IL-8,
and thiol group of animal model of COPD which is
comparable to the effect of dexamethasone at used
concentrations. Therefore, the results suggest a prevent-
ive therapeutic potential for Z. multiflora and its
constituent, carvacrol on lung inflammation and oxida-
tive stress in COPD.Competing interests
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